Sonova (OTCMKTS:SONVY - Get Free Report) was upgraded by stock analysts at Sanford C. Bernstein from a "hold" rating to a "strong-buy" rating in a research report issued on Friday,Zacks.com reports.

Other research analysts have also issued research reports about the stock. Hsbc Global Res lowered shares of Sonova from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, May 21st. BNP Paribas lowered shares of Sonova from a "strong-buy" rating to a "strong sell" rating in a research note on Wednesday, June 11th. Barclays lowered shares of Sonova from a "hold" rating to a "strong sell" rating in a research note on Friday, June 20th. HSBC cut shares of Sonova from a "buy" rating to a "hold" rating in a report on Wednesday, May 21st. Finally, Kepler Capital Markets raised shares of Sonova from a "strong sell" rating to a "hold" rating in a report on Friday, June 6th. Four equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold".

Check Out Our Latest Stock Report on SONVY

Shares of OTCMKTS SONVY opened at $58.30 on Friday. The firm has a 50-day simple moving average of $61.51 and a 200-day simple moving average of $62.42. The company has a current ratio of 1.27, a quick ratio of 0.96 and a debt-to-equity ratio of 0.45. Sonova has a 52 week low of $52.83 and a 52 week high of $77.56.

(Get Free Report)

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Before you consider Sonova, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sonova wasn't on the list.

While Sonova currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here